MCID: PPL021
MIFTS: 48

Papilledema

Categories: Eye diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Papilledema

MalaCards integrated aliases for Papilledema:

Name: Papilledema 12 76 53 29 55 15 73
Edema of the Optic Disc 53
Choked Disk 53

Classifications:



External Ids:

Disease Ontology 12 DOID:146
MeSH 44 D010211
NCIt 50 C3307
SNOMED-CT 68 73221001
UMLS 73 C0030353

Summaries for Papilledema

NIH Rare Diseases : 53 Papilledema is a condition in which increased pressure in or around the brain (intracranial pressure) causes swelling of the part of the optic nerve inside the eye (optic disc). Symptoms of increased intracranial pressure include headache or nausea and vomiting. Vision problems are not common initially, but may include short flickers of gray vision, blurred or double vision, and decreased field of vision or ability to see colors. Both eyes are usually affected. Papilledema by definition is caused by increased cranial pressure. Diagnosis includes a thorough eye exam by an ophthalmologist. Brain imaging studies (for example CT scan or MRI) are used to find the cause of the increased intracranial pressure. Treatment depends on the cause of the increased pressure but may include medications, surgery and/or weight management.

MalaCards based summary : Papilledema, also known as edema of the optic disc, is related to intracranial hypertension and ischemic optic neuropathy, and has symptoms including edema An important gene associated with Papilledema is TP53 (Tumor Protein P53), and among its related pathways/superpathways is IL1 and megakaryocytes in obesity. The drugs Acetazolamide and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include eye, brain and spinal cord, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 Papilledema (or papilloedema) is optic disc swelling that is caused by increased intracranial pressure... more...

Related Diseases for Papilledema

Diseases related to Papilledema via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 194)
# Related Disease Score Top Affiliating Genes
1 intracranial hypertension 32.5 APOH F2
2 ischemic optic neuropathy 30.2 APOH F2
3 intracranial hypertension, idiopathic 30.2 OGG1 PCLO SEMA6B
4 thrombophilia due to thrombin defect 30.2 APOH F2
5 cerebral sinovenous thrombosis 29.8 APOH F2
6 retinal vascular occlusion 29.8 APOH F2
7 hydrocephalus 11.4
8 papilloma of choroid plexus 11.3
9 optic papillitis 11.3
10 colloid cysts of third ventricle 11.0
11 pseudopapilledema 10.3
12 thrombosis 10.3
13 headache 10.2
14 anterior cranial fossa meningioma 10.2 F2 TP53
15 craniosynostosis 10.2
16 spinal cord infarction 10.2 APOH F2
17 sudden sensorineural hearing loss 10.2 APOH F2
18 prothrombin deficiency, congenital 10.2 APOH F2
19 ischemic colitis 10.2 APOH F2
20 sneddon syndrome 10.2 APOH F2
21 livedoid vasculitis 10.2 APOH F2
22 hepatic infarction 10.2 APOH F2
23 squamous cell papilloma 10.2 F2 TP53
24 thrombophlebitis 10.2 APOH F2
25 antithrombin iii deficiency 10.2 APOH F2
26 peripheral vertigo 10.2 APOH F2
27 buerger disease 10.2 APOH F2
28 central retinal vein occlusion 10.2 APOH F2
29 retinal vein occlusion 10.2 APOH F2
30 branch retinal artery occlusion 10.2 APOH F2
31 retinal artery occlusion 10.2 APOH F2
32 portal vein thrombosis 10.2 APOH F2
33 protein s deficiency 10.1 APOH F2
34 placental abruption 10.1 APOH F2
35 infective endocarditis 10.1 APOH F2
36 endocarditis 10.1 APOH F2
37 cholecystitis 10.1 F2 TP53
38 intermittent claudication 10.1 APOH F2
39 cataract 10.1
40 thrombophilia due to activated protein c resistance 10.1 APOH F2
41 barrett's adenocarcinoma 10.1 OGG1 TP53
42 budd-chiari syndrome 10.1 APOH F2
43 neuropathy 10.1
44 streptococcal meningitis 10.1 IL1R1 MYOM2
45 3-methylglutaconic aciduria, type iii 10.1
46 macular retinal edema 10.1
47 meningitis 10.1
48 mature b-cell neoplasm 10.0 MYOM2 TP53
49 antiphospholipid syndrome 10.0 APOH F2
50 malignant hypertension 10.0

Graphical network of the top 20 diseases related to Papilledema:



Diseases related to Papilledema

Symptoms & Phenotypes for Papilledema

UMLS symptoms related to Papilledema:


edema

GenomeRNAi Phenotypes related to Papilledema according to GeneCards Suite gene sharing:

26 (show all 26)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-102 9.8 PCLO
2 Increased shRNA abundance (Z-score > 2) GR00366-A-11 9.8 ARSB
3 Increased shRNA abundance (Z-score > 2) GR00366-A-110 9.8 ARSB
4 Increased shRNA abundance (Z-score > 2) GR00366-A-115 9.8 IL1R1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-122 9.8 ARSB F2 IL1R1 PCLO
6 Increased shRNA abundance (Z-score > 2) GR00366-A-124 9.8 IL1R1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-126 9.8 ARSB F2
8 Increased shRNA abundance (Z-score > 2) GR00366-A-133 9.8 F2
9 Increased shRNA abundance (Z-score > 2) GR00366-A-146 9.8 F2
10 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.8 F2
11 Increased shRNA abundance (Z-score > 2) GR00366-A-164 9.8 PCLO
12 Increased shRNA abundance (Z-score > 2) GR00366-A-166 9.8 PCLO
13 Increased shRNA abundance (Z-score > 2) GR00366-A-168 9.8 IL1R1
14 Increased shRNA abundance (Z-score > 2) GR00366-A-176 9.8 F2
15 Increased shRNA abundance (Z-score > 2) GR00366-A-183 9.8 IL1R1
16 Increased shRNA abundance (Z-score > 2) GR00366-A-198 9.8 IL1R1
17 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.8 PCLO
18 Increased shRNA abundance (Z-score > 2) GR00366-A-25 9.8 IL1R1
19 Increased shRNA abundance (Z-score > 2) GR00366-A-42 9.8 ARSB
20 Increased shRNA abundance (Z-score > 2) GR00366-A-43 9.8 ARSB F2
21 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.8 PCLO
22 Increased shRNA abundance (Z-score > 2) GR00366-A-83 9.8 ARSB
23 Increased shRNA abundance (Z-score > 2) GR00366-A-9 9.8 IL1R1
24 Increased shRNA abundance (Z-score > 2) GR00366-A-90 9.8 PCLO
25 Increased shRNA abundance (Z-score > 2) GR00366-A-99 9.8 IL1R1
26 Increased proliferation GR00094-A 8.96 IL1R1 TP53

MGI Mouse Phenotypes related to Papilledema:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.17 ARSB F2 IL1R1 OGG1 PCLO SEMA6B

Drugs & Therapeutics for Papilledema

Drugs for Papilledema (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 105)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetazolamide Approved, Vet_approved Phase 4,Phase 2,Phase 3 59-66-5 1986
2
Bevacizumab Approved, Investigational Phase 4,Phase 1,Phase 2 216974-75-3
3
Ranibizumab Approved Phase 4,Phase 2 347396-82-1 459903
4
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
5
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
6
Isotretinoin Approved Phase 4 4759-48-2 5538 5282379
7
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
8 diuretics Phase 4,Phase 2,Phase 3
9 Carbonic Anhydrase Inhibitors Phase 4,Phase 2,Phase 3
10 Anticonvulsants Phase 4,Phase 2,Phase 3
11 Natriuretic Agents Phase 4,Phase 2,Phase 3
12 Immunologic Factors Phase 4,Phase 1,Phase 2
13 Angiogenesis Inhibitors Phase 4,Phase 1,Phase 2
14 Angiogenesis Modulating Agents Phase 4,Phase 1,Phase 2
15 Endothelial Growth Factors Phase 4
16 Mitogens Phase 4
17 Pharmaceutical Solutions Phase 4,Not Applicable
18 Anti-Bacterial Agents Phase 4,Phase 2,Not Applicable
19 Anti-Infective Agents Phase 4,Phase 2
20 Dermatologic Agents Phase 4
21
Naproxen Approved, Vet_approved Phase 2, Phase 3 22204-53-1 1302 156391
22
Aspirin Approved, Vet_approved Phase 2, Phase 3,Not Applicable 50-78-2 2244
23
Codeine Approved, Illicit Phase 2, Phase 3 76-57-3 5284371
24
Guaifenesin Approved, Investigational, Vet_approved Phase 2, Phase 3 93-14-1 3516
25
Acetaminophen Approved Phase 2, Phase 3 103-90-2 1983
26
Ibuprofen Approved Phase 2, Phase 3 15687-27-1 3672
27
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3 50-02-2 5743
28
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3 1177-87-3
29
Warfarin Approved Phase 3 81-81-2 6691 54678486
30
Serine Approved, Nutraceutical Phase 3 56-45-1 5951
31 Anti-Inflammatory Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
32 glucocorticoids Phase 2, Phase 3,Phase 1
33 Hormone Antagonists Phase 2, Phase 3,Phase 1
34 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3,Phase 1
35 Hormones Phase 2, Phase 3,Phase 1
36 Analgesics, Non-Narcotic Phase 2, Phase 3,Not Applicable
37 Narcotics Phase 2, Phase 3
38 Central Nervous System Depressants Phase 2, Phase 3
39 Chlorpheniramine, phenylpropanolamine drug combination Phase 2, Phase 3
40 Anti-Inflammatory Agents, Non-Steroidal Phase 2, Phase 3,Not Applicable
41 Analgesics Phase 2, Phase 3,Not Applicable
42 Cyclooxygenase Inhibitors Phase 2, Phase 3
43 Respiratory System Agents Phase 2, Phase 3
44 Peripheral Nervous System Agents Phase 2, Phase 3,Phase 3,Not Applicable
45 Analgesics, Opioid Phase 2, Phase 3
46 Antipyretics Phase 2, Phase 3
47 Fibrinolytic Agents Phase 2, Phase 3
48 Platelet Aggregation Inhibitors Phase 2, Phase 3
49 Antirheumatic Agents Phase 2, Phase 3,Phase 1,Not Applicable
50 Antitussive Agents Phase 2, Phase 3

Interventional clinical trials:

(show all 40)
# Name Status NCT ID Phase Drugs
1 ALPI vs Medical Therapy Effects on Optic Nerve Structure & Function Unknown status NCT00485238 Phase 4 Intravenous acetazolamide
2 Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser Completed NCT03590444 Phase 4 Ranibizumab 0.5 MG/0.05 ML Intraocular Solution
3 Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study Completed NCT01486238 Phase 4 Macugen® pegaptanib sodium
4 Antiacne Medications Pseudotumor Cerebri Recruiting NCT02149615 Phase 4
5 Idiopathic Intracranial Hypertension Treatment Trial Completed NCT01003639 Phase 2, Phase 3 Acetazolamide;Placebo
6 Ozurdex for Macular Edema Post Membrane Peeling Completed NCT01273727 Phase 2, Phase 3 Dexamethasone;dexamethasone
7 Surgical Idiopathic Intracranial Hypertension Treatment Trial Recruiting NCT03501966 Phase 3 Acetazolamide
8 The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis Recruiting NCT03217448 Phase 3 Dabigatran etexilate;Warfarin
9 Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo Unknown status NCT01330524 Phase 1, Phase 2 Avastin and Triamcinolone
10 Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. Completed NCT02017444 Phase 2 AZD4017
11 Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF Recruiting NCT03071055 Phase 2 Ranibizumab Injection [Lucentis]
12 Intravitreal Aflibercept Injection for Radiation Retinopathy Trial Recruiting NCT03085784 Phase 2 Aflibercept
13 Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome Recruiting NCT02921893 Phase 2 Dexamethasone;Ixazomib Citrate;Lenalidomide
14 Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease Terminated NCT00069329 Phase 1, Phase 2 anakinra
15 Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection Terminated NCT01562132 Phase 2 Flucytosine and fluconazole;Fluconazole
16 Endovascular Stenting Treatment for Patients With Internal Jugular Vein Stenosis Not yet recruiting NCT03373292 Phase 1
17 aICP in Glaucoma and Papilledema Unknown status NCT02410148 Not Applicable
18 Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination Unknown status NCT02992262 Not Applicable
19 OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension Unknown status NCT02665858 Not Applicable
20 Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema Completed NCT01170481
21 Digital Ocular Fundus Photography in the Emergency Department: A New Application for Telemedicine? Completed NCT00873613 Not Applicable
22 Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI) Completed NCT01356134
23 Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery Completed NCT01847638 Not Applicable Prolensa (bromfenac 0.07%);Ilevro (nepafenac 0.3%)
24 Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting Completed NCT01318941 Ranibizumab
25 Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales Recruiting NCT03273179
26 Measurement of Optic Nerve Sheath Diameter in Children Without the Increased Intracranial Pressure Recruiting NCT03178760
27 Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome Recruiting NCT02896452
28 European Increlex® (Mecasermin [rDNA Origin] Injection) Growth Forum Database - IGFD Registry Recruiting NCT00903110 Increlex®
29 Venous Sinus Stenting With the River Stent in IIH Recruiting NCT03556085 Not Applicable
30 Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID / CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases) Recruiting NCT00059748
31 Evaluating Raised Intracranial Pressure Using MR Elastography Recruiting NCT03096743 Not Applicable
32 Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy Recruiting NCT03490318
33 Korean Registry of Target Organ Damages in Hypertension Recruiting NCT01861080
34 Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension Recruiting NCT02143258 Not Applicable
35 An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH Active, not recruiting NCT02124486 Not Applicable
36 Ocular Manifestations in Rheumatic Diseases Active, not recruiting NCT03753893
37 A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema Available NCT01487044 Macugen (Pegaptanib Sodium)
38 Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial Not yet recruiting NCT02513914 Not Applicable
39 Quality and Diagnostic Utility of Mydriatic Fundus Plenoptic Photography Suspended NCT03037268
40 Disc Edema in Patients With Chronic Kidney Disease Withdrawn NCT00769834

Search NIH Clinical Center for Papilledema

Genetic Tests for Papilledema

Genetic tests related to Papilledema:

# Genetic test Affiliating Genes
1 Papilledema 29

Anatomical Context for Papilledema

MalaCards organs/tissues related to Papilledema:

41
Eye, Brain, Spinal Cord, Bone, Prostate, Heart, Bone Marrow

Publications for Papilledema

Articles related to Papilledema:

(show top 50) (show all 541)
# Title Authors Year
1
Papilledema: Point-of-Care Ultrasound Diagnosis in the Emergency Department. ( 29849246 )
2018
2
Papilledema in Idiopathic Intracranial Hypertension. ( 29399792 )
2018
3
Optic Nerve Head and Macular Optical Coherence Tomography Measurements in Papilledema Compared With Pseudopapilledema. ( 29474199 )
2018
4
Bruch's membrane opening on optical coherence tomography in pediatric papilledema and pseudopapilledema. ( 29535052 )
2018
5
Chronic papilledema in a child with classical tuberous sclerosis. ( 29283138 )
2018
6
Re: Chang etA al.: Accuracy of diagnostic imaging modalities for classifying pediatric eyes as papilledema versus pseudopapilledema (Ophthalmology. 2017;124:1839-1848). ( 29458838 )
2018
7
The Translaminar Pressure Gradient: Papilledema after Trabeculectomy Treated with Optic Nerve Sheath Fenestration. ( 29979338 )
2018
8
Young Man With Severe Bilateral Papilledema. ( 29800986 )
2018
9
Papilledema revisiting after sinus angioplasty of chronic cerebral venous sinus thrombosis. ( 29676328 )
2018
10
Rapid effect of depletive lumbar puncture on papilledema in intracranial hypertension. ( 29903588 )
2018
11
Five-Year-Old Boy With Behavioral Changes and Papilledema. ( 28991098 )
2018
12
Arteriovenous ratio and papilledema based hybrid decision support system for detection and grading of hypertensive retinopathy. ( 29249337 )
2018
13
Syphilis-Related Eye Disease Presenting as Bilateral Papilledema, Retinal Nerve Fiber Layer Hemorrhage, and Anterior Uveitis in a Penicillin-Allergic Patient. ( 29670780 )
2018
14
Headache and Papilledema in Guillain-BarrAc Syndrome. ( 29374500 )
2018
15
Multisuture Craniosynostosis and Papilledema in Pycnodysostosis: A Paradox? ( 30394969 )
2018
16
Headache Characteristics in Children With Pseudotumor Cerebri Syndrome, Elevated Opening Pressure Without Papilledema, and Normal Opening Pressure: A Retrospective Cohort Study. ( 30137653 )
2018
17
Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache. ( 29997572 )
2018
18
Metastatic craniocervical hemangiopericytoma presenting with hydrocephalus and papilledema - Case review. ( 30318074 )
2018
19
Neuro-Behcet's disease in a case with papilledema and intracranial hypertension as the initial presentation. ( 30374484 )
2018
20
Optical coherence tomography angiography in acute unilateral nonarteritic anterior ischemic optic neuropathy: A comparison with the fellow eye and with eyes with papilledema. ( 30038161 )
2018
21
Early Macular Vessel Density Loss in Acute Ischemic Optic Neuropathy Compared to Papilledema: Implications for Pathogenesis. ( 30271677 )
2018
22
Bruch's membrane opening on optical coherence tomography in pediatric papilledema and pseudopapilledema. ( 29535053 )
2018
23
Re: Chang et al.: Accuracy of diagnostic imaging modalities for classifying pediatric eyes as papilledema versus pseudopapilledema (Ophthalmology. 2017;124:1839-1848). ( 30143102 )
2018
24
Pediatric Papilledema: Review and a Clinical Care Algorithm. ( 30239361 )
2018
25
Masking of Papilledema by Glaucoma. ( 30532370 )
2018
26
Cerebral Venous Thrombosis: An Uncommon Cause of Papilledema on Bedside Ocular Ultrasound. ( 30538085 )
2018
27
Re: Re: The Translaminar Pressure Gradient: Papilledema after Trabeculectomy Treated with Optic Nerve Sheath Fenestration. ( 30540674 )
2018
28
Re: Radke et al - The Translaminar Pressure Gradient - Papilledema After Trabeculectomy Treated With Optic Nerve Sheath Fenestration. ( 30540675 )
2018
29
Decision Support System for Detection of Papilledema through Fundus Retinal Images. ( 28283997 )
2017
30
Unexpected papilledema in a young male with Type 1 diabetes. ( 28781853 )
2017
31
"Twin Peaks" Papilledema. ( 28126073 )
2017
32
Relationship between lamina cribrosa displacement and trans-laminar pressure difference in papilledema. ( 28391369 )
2017
33
Factors Influencing the Incidence of Papilledema in Patients with Cerebral Venous Thrombosis. ( 29387676 )
2017
34
Fully automated diagnosis of papilledema through robust extraction of vascular patterns and ocular pathology from fundus photographs. ( 28270999 )
2017
35
Vestibular Schwannoma Presenting with Bilateral Papilledema Without Hydrocephalus: Case Study. ( 29375948 )
2017
36
Optical Coherence Tomography to Differentiate Papilledema from Pseudopapilledema. ( 28819712 )
2017
37
Commentary: The Dilemma of Papilledema in Chiari I Malformation. ( 29272471 )
2017
38
Retrospective analysis of translaminar, demographic, and physiologic parameters in relation to papilledema severity. ( 28237144 )
2017
39
Papilledema in children with hydrocephalus: incidence and associated factors. ( 28387641 )
2017
40
Utility of Intracranial Pressure Monitoring for Diagnosis of Idiopathic Intracranial Hypertension in the Absence of Papilledema. ( 29258930 )
2017
41
The diagnostic challenge of evaluating papilledema in the pediatric patient. ( 29018749 )
2017
42
Complete Resolution of Papilledema in Syndromic Craniosynostosis with Posterior Cranial Vault Distraction. ( 28904587 )
2017
43
Clinical Reasoning: A 57-year-old man with unilateral anosmia, papilledema, and meningismus. ( 28827465 )
2017
44
Sildenafil-related cerebral venous sinus thrombosis and papilledema: a case report of a rare entity. ( 28474148 )
2017
45
Accuracy of Diagnostic Imaging Modalities for Classifying Pediatric Eyes as Papilledema Versus Pseudopapilledema. ( 28732589 )
2017
46
Accuracy of crescent sign on ocular ultrasound in diagnosing papilledema. ( 29026691 )
2017
47
Bruch's membrane opening on optical coherence tomography in pediatric papilledema and pseudopapilledema. ( 29203329 )
2017
48
Papilledema: A Comprehensive Assessment. ( 29204042 )
2017
49
Myhre syndrome with novel findings: bilateral congenital cortical cataract, bilateral papilledema, accessory nipple, and adenoid hypertrophy. ( 28562390 )
2017
50
Orbital Hydatid Cyst Causing Papilledema and Proptosis in an Adult. ( 28323190 )
2017

Variations for Papilledema

Expression for Papilledema

Search GEO for disease gene expression data for Papilledema.

Pathways for Papilledema

Pathways related to Papilledema according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.02 F2 IL1R1

GO Terms for Papilledema

Biological processes related to Papilledema according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nucleotide-excision repair GO:0006289 9.4 OGG1 TP53
2 base-excision repair GO:0006284 9.37 OGG1 TP53
3 positive regulation of reactive oxygen species metabolic process GO:2000379 9.32 F2 TP53
4 blood coagulation, intrinsic pathway GO:0007597 9.26 APOH F2
5 positive regulation of blood coagulation GO:0030194 9.16 APOH F2
6 regulation of blood coagulation GO:0030193 8.96 APOH F2
7 negative regulation of fibrinolysis GO:0051918 8.62 APOH F2

Sources for Papilledema

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....